ATE298766T1 - Veränderung der herstellung von alpha-interferon - Google Patents
Veränderung der herstellung von alpha-interferonInfo
- Publication number
- ATE298766T1 ATE298766T1 AT99965674T AT99965674T ATE298766T1 AT E298766 T1 ATE298766 T1 AT E298766T1 AT 99965674 T AT99965674 T AT 99965674T AT 99965674 T AT99965674 T AT 99965674T AT E298766 T1 ATE298766 T1 AT E298766T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrrolidinone
- methyl
- aliphatic
- production
- cyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9804583A SE513313C2 (sv) | 1998-12-29 | 1998-12-29 | Modifierad interferonproduktion |
PCT/SE1999/002446 WO2000039163A1 (en) | 1998-12-29 | 1999-12-22 | Modification of interferon alpha production |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE298766T1 true ATE298766T1 (de) | 2005-07-15 |
Family
ID=20413894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99965674T ATE298766T1 (de) | 1998-12-29 | 1999-12-22 | Veränderung der herstellung von alpha-interferon |
Country Status (15)
Country | Link |
---|---|
US (1) | US6962695B1 (de) |
EP (1) | EP1141012B1 (de) |
JP (1) | JP4584456B2 (de) |
AT (1) | ATE298766T1 (de) |
AU (1) | AU2136200A (de) |
CA (1) | CA2354025C (de) |
CZ (1) | CZ301888B6 (de) |
DE (1) | DE69926013T2 (de) |
ES (1) | ES2244239T3 (de) |
HK (1) | HK1040086B (de) |
HU (1) | HU227164B1 (de) |
NO (1) | NO328424B1 (de) |
PT (1) | PT1141012E (de) |
SE (1) | SE513313C2 (de) |
WO (1) | WO2000039163A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE513313C2 (sv) * | 1998-12-29 | 2000-08-21 | Bionative Ab | Modifierad interferonproduktion |
JP2009298752A (ja) * | 2008-06-17 | 2009-12-24 | Shiseido Co Ltd | 皮膚外用剤組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932617A (en) * | 1974-05-24 | 1976-01-13 | The Upjohn Company | Interferon induction |
US4027021A (en) | 1974-08-23 | 1977-05-31 | The Upjohn Company | Interferon induction |
CS215108B2 (en) | 1977-07-15 | 1982-07-30 | Wellcome Found | Method of making the interferrone |
DE2961658D1 (en) | 1978-05-17 | 1982-02-18 | Thomae Gmbh Dr K | Process for preparing human interferon |
JPS56135420A (en) * | 1980-03-26 | 1981-10-22 | Fumiaki Taguchi | Suppressive substance of virus and its preparation |
IT1172270B (it) * | 1982-06-21 | 1987-06-18 | Wellcome Found | Procedimento per la produzione di interferon |
SE513313C2 (sv) * | 1998-12-29 | 2000-08-21 | Bionative Ab | Modifierad interferonproduktion |
-
1998
- 1998-12-29 SE SE9804583A patent/SE513313C2/sv not_active IP Right Cessation
-
1999
- 1999-12-22 PT PT99965674T patent/PT1141012E/pt unknown
- 1999-12-22 AT AT99965674T patent/ATE298766T1/de active
- 1999-12-22 US US09/869,269 patent/US6962695B1/en not_active Expired - Fee Related
- 1999-12-22 WO PCT/SE1999/002446 patent/WO2000039163A1/en active IP Right Grant
- 1999-12-22 ES ES99965674T patent/ES2244239T3/es not_active Expired - Lifetime
- 1999-12-22 JP JP2000591074A patent/JP4584456B2/ja not_active Expired - Fee Related
- 1999-12-22 HU HU0104761A patent/HU227164B1/hu not_active IP Right Cessation
- 1999-12-22 CZ CZ20011951A patent/CZ301888B6/cs not_active IP Right Cessation
- 1999-12-22 AU AU21362/00A patent/AU2136200A/en not_active Abandoned
- 1999-12-22 EP EP99965674A patent/EP1141012B1/de not_active Expired - Lifetime
- 1999-12-22 CA CA2354025A patent/CA2354025C/en not_active Expired - Fee Related
- 1999-12-22 DE DE69926013T patent/DE69926013T2/de not_active Expired - Lifetime
-
2001
- 2001-06-28 NO NO20013243A patent/NO328424B1/no not_active IP Right Cessation
-
2002
- 2002-03-07 HK HK02101764.0A patent/HK1040086B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2000039163A1 (en) | 2000-07-06 |
CZ20011951A3 (cs) | 2002-02-13 |
NO20013243D0 (no) | 2001-06-28 |
DE69926013T2 (de) | 2006-05-18 |
DE69926013D1 (de) | 2005-08-04 |
HUP0104761A3 (en) | 2004-07-28 |
HK1040086A1 (en) | 2002-05-24 |
ES2244239T3 (es) | 2005-12-01 |
AU2136200A (en) | 2000-07-31 |
HK1040086B (zh) | 2006-01-20 |
SE513313C2 (sv) | 2000-08-21 |
CA2354025A1 (en) | 2000-07-06 |
JP4584456B2 (ja) | 2010-11-24 |
CA2354025C (en) | 2012-05-22 |
SE9804583L (sv) | 2000-06-30 |
PT1141012E (pt) | 2006-06-30 |
JP2002533112A (ja) | 2002-10-08 |
US6962695B1 (en) | 2005-11-08 |
NO20013243L (no) | 2001-06-28 |
EP1141012A1 (de) | 2001-10-10 |
CZ301888B6 (cs) | 2010-07-21 |
SE9804583D0 (sv) | 1998-12-29 |
HUP0104761A2 (hu) | 2002-04-29 |
HU227164B1 (en) | 2010-09-28 |
EP1141012B1 (de) | 2005-06-29 |
NO328424B1 (no) | 2010-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL990030I1 (nl) | Derivaten en analogen van 2-deoxy-2,3-didehydro-N-acetylneuraminezuur en het gebruik ervan als antivirale middelen. | |
BR9814361A (pt) | Inibição de quinase raf usando uréiasheterocìclicas substituìdas por arila eheteroarila | |
BR9913406A (pt) | Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção | |
DK0653439T3 (da) | Stabiliserede oligonukleotider og anvendelse heraf | |
CY1105344T1 (el) | Αμινουχα παραγωγα της διυδρο- 1,3,5 - τριαζινης και οι εφαρμογες τους στη θepαπευτικη | |
HRP20050417B1 (hr) | Antiviralni derivati nukleozida | |
DE60143672D1 (de) | Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation | |
DE69025529D1 (de) | Weitere antivirale Pyrimidin-Nukleosiden | |
ATE154029T1 (de) | 7-deazapurin modifizierte oligonukleotide | |
ATE355380T1 (de) | Methode zur selektiven inaktivierung der viralen replication | |
ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
DE60039729D1 (de) | N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen | |
PT97754A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo pelo menos um agente inibidor da poli-(adp-ribose)-polimerase nomeadamente, uma amida aromatica, para o tratamento de infeccoes provocadas por virus | |
DE69932154D1 (de) | Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen | |
ATE124412T1 (de) | Antivirusderivate von (phosphonmethoxy)methoxy purin/pyrimidin. | |
PT96379A (pt) | Processo de preparacao de ciclopropil-n-hidroxi-ureias,-carboxamidas e n-acil-n-hidroxiaminas substituidas e de composicoes farmaceuticas | |
DE69830241D1 (de) | Verwendung von n-substituierten 1,5-dideoxy-1,5-imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen | |
ATE281179T1 (de) | Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür | |
ATE298766T1 (de) | Veränderung der herstellung von alpha-interferon | |
ATE77234T1 (de) | Aromatische verbindungen mit amider struktur, derivate von aminobenzoesaeuren, hydroxybenzoesaeuren, zimtsaeuren, urocansaeuren und benzimidazolen, die uvb und/oder uva absorbieren. | |
DK1068209T3 (da) | Fremgangsmåde til fremstilling af purinderivater og deres mellemprodukter | |
DK0443918T3 (da) | Hidtil ukendte derivater af 20,21-dinoreburnamenin, deres fremstilling og anvendelse som lægemidler, samt mellemprodukter og farmaceutiske peæparater med indhold heraf | |
ES2187939T3 (es) | Moleculas aisladas de acido nucleico codificantes de miembros de la familia ssx y utilizaciones de las mismas. | |
DE60044937D1 (de) | Analoge des 5(e)bromovinyluracils und verwandte pyrimidinnucleoside als antivirale mittel und verwendungsmethoden | |
TH4918A (th) | อนุพันธ์ของไพริมิดีน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1141012 Country of ref document: EP |
|
EEIH | Change in the person of patent owner |